Delirium in Old Age
Conditions
Keywords
Delirium, Prevention, Cognitive stimulation
Brief summary
This study is a pilot randomized controlled trial, comparing a group of older patients with standardized non-pharmacological delirium prevention plus a basic tablet versus a group with standardized non-pharmacological delirium prevention plus a tablet with a software of cognitive stimulation (PREVEDEL). Software:It is a local development, including a interprofessional team of delirium healthcare experts, older patients and a team og engineers. The software was developed during the first year of this project and was inscribed for author rights. Inclusion criteria: Older patients \> 65 y.o. Admitted to medicine room or intermediate care unit \> 48 hrs, and informed consent to participate. Exclusion Criteria:Delirium positive, neuroleptic use, dementia, and non-spanish speakers. The study was approved by ethical committee of Hospital Clinico University of Chile Standardized Non-pharmacological intervention: Health workers were previously educated in delirium, and environmental issues were implemented. This intervention coverage in nine different domains: orientation, early mobilization, environmental noise and light, sensorial deficit, sleep, hydratation, drug reduction, and family participation. Intervention: All patients will have a tablet with or without the software PREVEDEL between 09:00-19:00 hrs. Measures: delirium will be monitoring with CAM (Confusion Assessment Method) twice a day for 5 days. Primary outcome: Delirium rate between both groups Secondary outcomes:Long of stay, severity od delirium, time of use of electronic device, and Barthel to discharge.
Interventions
All patients will have a tablet with the software PREVEDEL between 09:00-19:00 hrs.
All patients will have a tablet without the software PREVEDEL between 09:00-19:00 hrs.
Sponsors
Study design
Eligibility
Inclusion criteria
Older patients \> 65 y.o. Admitted to medicine room or intermediate care unit \> 48 hrs, and informed consent to participate.
Exclusion criteria
Delirium positive, neuroleptic use, dementia, and non-spanish speakers.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Difference in delirium incidence between both groups | 5 days | Delirium will be assessed with CAM (the confusion assessment method) twice a day. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Length of stay | 5 days | The days of total hospital stay of the patients will be recorded |
| Severity of delirium | 5 days | Delirium will be evaluated with CAM-S (the confusion assessment method Severity) whenever appropriate. |
| Time of use of electronic device | 5 days | The usage time on the mobile device (with internal device registration) will be recorded. |
| Functionality at discharge. | 5 days | Functionality at discharge will be assessed with Barthel Index test at discharge. |
Countries
Chile